Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
Alnylam Pharma (0HD2) Ownership - Who Owns Alnylam Pharma?
0 Followers
Alnylam Pharma (0HD2) Ownership Overview
The ownership structure of Alnylam Pharma (GB:0HD2) stock is a mix of institutional, retail and individual investors. Approximately 38.95% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 61.05% is owned by Public Companies and Individual Investors.
0.00% Insiders
0.00% Mutual Funds
38.95% Other Institutional Investors
61.05% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 07, 2023 | Garg Pushkal Cmo & Evp Dev & Med Affairs | Sold | $643223 |
| Aug 07, 2023 | Yvonne Greenstreet Ceo,director | Sold | $753986 |
| Aug 07, 2023 | Poulton Jeffrey V. Evp & Cfo | Sold | $643037 |
| Aug 07, 2023 | Akshay Vaishnaw President | Sold | $753986 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Sold | $252721 | |
| Sep 30, 2023 | Bought | $334010 | |
| Sep 30, 2023 | Sold | $545822 | |
| Sep 30, 2023 | Bought | $3893543 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,869.00 | Insider | ― | 3,492,572.82 | |
| 306,996.00 | Insider | ― | 53,963,756.88 | |
| 839.00 | Insider | ― | 147,479.42 | |
| 73,501.00 | Insider | ― | 12,920,005.78 | |
| 23,289.00 | Insider | ― | 4,093,740.42 | |
| 266,899.00 | Insider | ― | 46,915,506.22 | |
| 8,891.00 | Insider | ― | 1,562,859.98 | |
| 10,256,633.00 | Insider | ― | 1,802,910,948.74 | |
| 230,796.00 | Insider | ― | 40,569,320.88 | |
| 136.00 | Insider | ― | 23,906.08 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,166.00 | Institution | ― | 908,079.48 | |
| 250.00 | Institution | ― | 43,945.00 | |
| 56,568.00 | Institution | ― | 9,943,523.04 | |
| 180,373.00 | Institution | ― | 31,705,965.94 | |
| 272,876.00 | Institution | ― | 47,966,143.28 | |
| 11,883.00 | Institution | ― | 2,088,793.74 | |
| 51,110.00 | Institution | ― | 8,984,115.80 | |
| 297,712.00 | Institution | ― | 52,331,815.36 | |
| 16,519.00 | Institution | ― | 2,903,709.82 | |
| 12,425.00 | Institution | ― | 2,184,066.50 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Alnylam Pharmaceuticals (GB:0HD2)?
According to the latest TipRanks data, approximately 38.95% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 61.05% is held by retail investors.
What percentage of Alnylam Pharmaceuticals (GB:0HD2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.95% of Alnylam Pharmaceuticals (GB:0HD2) stock is held by institutional investors.
What percentage of Alnylam Pharmaceuticals (GB:0HD2) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.05% of Alnylam Pharmaceuticals (GB:0HD2) stock is held by retail investors.
Who owns the most shares of Alnylam Pharmaceuticals (GB:0HD2)?
Laurence Reid owns the most shares of Alnylam Pharmaceuticals (GB:0HD2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.